US Patent Issued to THE BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM on Sept. 1 for "Monoclonal antibodies against LILRB1 for diagnostic and therapeutic use" (Texas Inventors)

ALEXANDRIA, Va., Sept. 1 -- United States Patent no. 12,723,078, issued on Sept. 1, was assigned to THE BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM (Austin, Texas).

"Monoclonal antibodies against LILRB1 for diagnostic and therapeutic use" was invented by Zhiqiang An (Houston), Chengcheng Zhang (Southlake, Texas), Ningyan Zhang (Houston), Yuanzhi Chen (Houston) and Heyu Chen (Dallas).

According to the abstract* released by the U.S. Patent & Trademark Office: "Provided herein are antibodies binding to LILRB1 and the uses of the antibodies in detecting and treating cancer and autoimmune diseases."

The patent was filed on July 26, 2021, under Application No. 18/007,185.

*For further information, including images, charts and tables, p...